Case-Based Roundtable Meetings Spotlight: April 1 2022

Experts Discuss Treatment Options in 2 Patients With Metastatic RCC

April 21, 2022

Clinical Articles

Scott S. Tykodi, MD, PhD, and Ulka N. Vaishampayan, MBBS, discussed treatment for patients with relapsed and late-stage renal cell carcinoma based on National Comprehensive Cancer Network guidelines and recent clinical trials.

Tewari Reviews Maintenance Treatments for Patients With Advanced Ovarian Cancer

April 18, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable discussion, Krishnansu S. Tewari, MD, discussed the use of bevacizumab, niraparib, and olaparib for patients who have completed primary chemotherapy for advanced ovarian cancer.

Choudhury Discusses Sequencing of Therapy in Metastatic Castration-Resistant Prostate Cancer

April 16, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Atish D. Choudhury, MD, PhD, discussed the CARD trial of cabazitaxel and the VISION trial of lutetium-177 for patients with metastatic castration-resistant prostate cancer.

Hutson Reviews Multiple Combination Trials for Patients With RCC

April 15, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Thomas Hutson, DO, PharmaD, discussed immunotherapy and tyrosine kinase inhibitor combinations for frontline therapy of renal cell carcinoma.